Oncology Institute, Inc. Balance Sheet
TOI|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Oncology Institute, Inc. had $165M in total assets and $4M in shareholders' equity as of FY2025. Total debt stood at $77M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Accounts Receivable | $59.0M | $48.3M | $42.4M | $39.8M | $20.0M |
| Inventory | $16.9M | $10.0M | $13.7M | $9.3M | $6.4M |
| Current Assets | $112.7M | $112.4M | $143.5M | $130.4M | $154.1M |
| PP&E (Net) | $10.7M | $11.9M | $10.9M | $8.5M | $4.2M |
| Goodwill | $7.2M | $7.2M | $7.2M | $21.4M | $26.6M |
| Total Assets | $164.7M | $172.7M | $209.2M | $261.7M | $203.4M |
| Current Liabilities | $71.0M | $52.2M | $34.8M | $29.7M | $29.8M |
| Total Debt | $77.4M | $93.1M | $86.8M | $80.6M | $0 |
| Shareholders' Equity | $3.6M | $57.0M | $123.2M | $104.2M | $28.1M |